0001493152-23-001806.txt : 20230119 0001493152-23-001806.hdr.sgml : 20230119 20230118183256 ACCESSION NUMBER: 0001493152-23-001806 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230118 EFFECTIVENESS DATE: 20230119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Soricimed Biopharma Inc. CENTRAL INDEX KEY: 0001532755 IRS NUMBER: 000000000 STATE OF INCORPORATION: A3 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-431623 FILM NUMBER: 23535481 BUSINESS ADDRESS: STREET 1: 18 BOTSFORD STREET STREET 2: SUITE 201 CITY: MONCTON STATE: A3 ZIP: E1C 4W7 BUSINESS PHONE: 1(506)872-2181 MAIL ADDRESS: STREET 1: 18 BOTSFORD STREET STREET 2: SUITE 201 CITY: MONCTON STATE: A3 ZIP: E1C 4W7 D/A 1 primary_doc.xml X0708 D/A LIVE 0001532755 Soricimed Biopharma Inc. 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 (506) 856-0400 NEW BRUNSWICK, CANADA BioProspecting NB Inc. None Corporation true Robert Bruce 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Executive Officer Chief Executive Officer Jack Stewart 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Executive Officer Director Chief Science Officer and Director Paul Gunn 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Executive Officer Director President and Director Vaughn Embro-Pantelony 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Director Chair Marc Rubin 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Director Camille Belliveau 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Director Susan Hicks 18 BOTSFORD STREET SUITE 201 MONCTON A3 NEW BRUNSWICK, CANADA E1C 4W7 Director Biotechnology Decline to Disclose 06c true 0001493152-22-002763 2021-07-23 true true false 7859 3732179 2775233 956946 false 45 0 0 0 false Soricimed Biopharma Inc. /s/ Robert Bruce Robert Bruce Chief Executive Officer 2023-01-18